First Trust Advisors
KYNB

First Trust Advisors’s Kyntra Bio KYNB Stock Holding History

First Trust Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,737
Closed -$6.8M – 2408
2023
Q2 		$6.8M Sell
100,737
-8,102
-7% -$3.35M 0.01% 1123
2023
Q1 		$50.8M Sell
108,839
-10,187
-9% -$5.39M 0.06% 438
2022
Q4 		$47.7M Sell
119,026
-26,019
-18% -$9.97M 0.06% 460
2022
Q3 		$47.2M Sell
145,045
-18,273
-11% -$5.88M 0.06% 445
2022
Q2 		$43.1M Buy
163,318
+24,159
+17% +$6.17M 0.05% 480
2022
Q1 		$41.8M Sell
139,159
-73,546
-35% -$25.6M 0.04% 539
2021
Q4 		$75M Buy
212,705
+42,222
+25% +$13.1M 0.07% 345
2021
Q3 		$43.6M Buy
170,483
+46,210
+37% +$16.4M 0.05% 497
2021
Q2 		$82.7M Buy
124,273
+59,088
+91% +$34M 0.09% 295
2021
Q1 		$56.6M Buy
65,185
+8,486
+15% +$9.04M 0.07% 415
2020
Q4 		$52.6M Sell
56,699
-10,119
-15% -$10.6M 0.07% 409
2020
Q3 		$68.7M Sell
66,818
-572
-0.8% -$615K 0.11% 232
2020
Q2 		$68.3M Buy
67,390
+14,678
+28% +$13.6M 0.12% 213
2020
Q1 		$45.8M Buy
52,712
+425
+0.8% +$422K 0.1% 302
2019
Q4 		$56.1M Sell
52,287
-125
-0.2% -$128K 0.1% 309
2019
Q3 		$48.5M Sell
52,412
-29,436
-36% -$32.3M 0.09% 308
2019
Q2 		$92.4M Buy
81,848
+5,830
+8% +$6.38M 0.17% 143
2019
Q1 		$103M Buy
76,018
+7,721
+11% +$10.5M 0.21% 116
2018
Q4 		$79M Buy
68,297
+2,208
+3% +$2.48M 0.19% 119
2018
Q3 		$100M Buy
66,089
+18,132
+38% +$27.9M 0.19% 111
2018
Q2 		$75.1M Buy
47,957
+7,791
+19% +$10.2M 0.16% 132
2018
Q1 		$46.4M Buy
40,166
+9,100
+29% +$12M 0.11% 209
2017
Q4 		$36.8M Buy
31,066
+28,384
+1,058% +$35.6M 0.09% 289
2017
Q3 		$3.61M Buy
2,682
+1,940
+261% +$2.04M 0.01% 1140
2017
Q2 		$599K Buy
+742
New +$517K ﹤0.01% 2022
2016
Q1 		– Sell
-408
Closed -$311K – 2236
2015
Q4 		$311K Buy
+408
New +$271K ﹤0.01% 2069

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors's KYNB Position: Q3 2023 in Review

First Trust Advisors sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 100,737 shares — an estimated $6.8M sold.

First Trust Advisors first reported a position in KYNB in Q4 2015 and held it in 26 quarters. The position peaked at $103M in Q1 2019. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • First Trust Advisors reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • First Trust Advisors sold 100,737 Kyntra Bio shares in Q3 2023, an estimated $6.8M.
  • First Trust Advisors first reported a position in Kyntra Bio in Q4 2015 and held it in 26 quarters.
  • First Trust Advisors's Kyntra Bio position peaked at $103M in Q1 2019.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.